Tınaztepe Sağlık Valuation Multiples

Tınaztepe Sağlık is valued at $234M as of September 2026, a 3.1x revenue multiple. In the last fiscal year, Tınaztepe Sağlık revenue was $70M and Tınaztepe Sağlık EBITDA was $22M.

Tınaztepe Sağlık Overview

About Tınaztepe Sağlık

Tapdi Oksijen Ozel Saglik ve Egitim Hizlmetleri Sanayi Ticaret AS operates in the general medical and surgical hospitals sector. The company provides service in İzmir with a medical center and two full fledged hospitals.


Founded

2001

HQ

Turkey

Employees

N/A

Financials (Last FY)

Revenue: $70M
EBITDA: $22M

EV

$218M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Tınaztepe Sağlık Financials

Tınaztepe Sağlık reported last fiscal year revenue of $70M and EBITDA of $22M.

In the same fiscal year, Tınaztepe Sağlık generated $29M in gross profit, $22M in EBITDA, and $14M in net income.


Tınaztepe Sağlık P&L

In the most recent fiscal year, Tınaztepe Sağlık reported revenue of $70M and EBITDA of $22M.

Tınaztepe Sağlık is profitable as of last fiscal year, with gross margin of 41%, EBITDA margin of 31%, and net margin of 20%.

See analyst estimates for Tınaztepe Sağlık
Last FY2025202620272028
Revenue$70M$70M
Gross Profit$29M$29M
Gross Margin41%41%
EBITDA$22M$22M
EBITDA Margin31%31%
EBIT Margin28%28%
Net Profit$14M$14M
Net Margin20%20%
Net Debt($6M)-

Financial data powered by Morningstar, Inc.

Tınaztepe Sağlık Stock Performance

Tınaztepe Sağlık has current market cap of $234M, and enterprise value of $218M.


Tınaztepe Sağlık's stock price is $0.59.

Tınaztepe Sağlık has an EPS (earnings per share) of $0.04.

See more trading valuation data for Tınaztepe Sağlık
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$218M$234M-0.7%---$0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Tınaztepe Sağlık Valuation Multiples

Tınaztepe Sağlık trades at 3.1x EV/Revenue multiple, and 10.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Tınaztepe Sağlık

Tınaztepe Sağlık Financial Valuation Multiples

As of September 24, 2026, Tınaztepe Sağlık has market cap of $234M and EV of $218M.

Tınaztepe Sağlık has a P/E ratio of 16.5x.

Last FY2025202620272028
EV/Revenue3.1x3.1x
EV/EBITDA10.1x10.1x
EV/EBIT10.9x10.9x
EV/Gross Profit7.6x7.6x
P/E16.5x16.5x
EV/FCFn/mn/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Tınaztepe Sağlık Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Tınaztepe Sağlık Margins & Growth Rates

In the most recent fiscal year, Tınaztepe Sağlık reported gross margin of 41%, EBITDA margin of 31%, and net margin of 20%.

See estimated margins and future growth rates for Tınaztepe Sağlık

Tınaztepe Sağlık Margins

Last FY2025202720282029
Gross Margin41%41%
EBITDA Margin31%31%
EBIT Margin28%28%
Net Margin20%20%
FCF Margin(1%)(1%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Tınaztepe Sağlık Operational KPIs

Access forward-looking KPIs for Tınaztepe Sağlık
Last FY2025202620272028
S&M Expenses to Revenue0%0%
G&A Expenses to Revenue1%1%
Opex to Revenue13%13%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Tınaztepe Sağlık Competitors

Tınaztepe Sağlık competitors include Atrys Health, Monash IVF Group, Oncoclínicas, Suraksha Diagnostics, Pihlajalinna, Goodwill Pharma, Limes Schlosskliniken, Medica Sur, MediClin and Shalby.

Most Tınaztepe Sağlık public comparables operate across Hospitals & Clinics.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Atrys Health$161M($12M)2.3x2.1x(30.3x)13.3x
Monash IVF Group$193M$46M1.8x1.8x7.4x8.9x
Oncoclínicas$1.1B($438M)0.9x0.9x(2.3x)7.3x
Suraksha Diagnostics$32M$10M6.3x5.8x20.4x18.4x
Pihlajalinna$747M$125M0.6x0.7x3.9x4.2x
Goodwill Pharma$72M$19M2.9x-11.2x-
Limes Schlosskliniken$57M$15M3.2x2.7x12.6x10.9x
Medica Sur$276M$57M0.9x1.0x4.6x4.7x

This data is available for Pro users. Sign up to see all Tınaztepe Sağlık competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Tınaztepe Sağlık

When was Tınaztepe Sağlık founded?Tınaztepe Sağlık was founded in 2001.
Where is Tınaztepe Sağlık headquartered?Tınaztepe Sağlık is headquartered in Turkey.
Is Tınaztepe Sağlık publicly listed?Yes, Tınaztepe Sağlık is a public company listed on Borsa Istanbul.
What is the stock symbol of Tınaztepe Sağlık?Tınaztepe Sağlık trades under TNZTP ticker.
When did Tınaztepe Sağlık go public?Tınaztepe Sağlık went public in 2023.
Who are competitors of Tınaztepe Sağlık?Tınaztepe Sağlık main competitors include Atrys Health, Monash IVF Group, Oncoclínicas, Suraksha Diagnostics, Pihlajalinna, Goodwill Pharma, Limes Schlosskliniken, Medica Sur, MediClin, Shalby.
What is the current market cap of Tınaztepe Sağlık?Tınaztepe Sağlık's current market cap is $234M.
What is the current revenue of Tınaztepe Sağlık?Tınaztepe Sağlık's last fiscal year revenue is $70M.
What is the current EV/Revenue multiple of Tınaztepe Sağlık?Current revenue multiple of Tınaztepe Sağlık is 3.1x.
Is Tınaztepe Sağlık profitable?No, Tınaztepe Sağlık is not profitable.
How many companies Tınaztepe Sağlık has acquired to date?Tınaztepe Sağlık hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Tınaztepe Sağlık has invested to date?Tınaztepe Sağlık hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Tınaztepe Sağlık

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial